Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Optimal treatment for aromatase inhibitor-resistant metastatic breast cancer patients: Lessons from the PEARL study.

Auteurs : Agostinetto E, Ignatiadis M
Jaar : 2021
Journal : Ann Oncol

Liquid biopsy enters the clinic - implementation issues and future challenges.

Auteurs : Ignatiadis M, Sledge GW, Jeffrey SS
Jaar : 2021
Journal : Nat Rev Clin Oncol
Volume : 18
Pagina's : 297-312

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients.

Auteurs : Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, De Schepper M, Geukens T, Lucidi V, Ignatiadis M, Aftimos P, Sotiriou C, Piccart-Gebhart M, Hendlisz A, Van Laere S, Dirix L, Noël JC, Biganzoli E, Larsimont D, Desmedt C, Donckier V
Jaar : 2020
Journal : NPJ Breast Cancer
Volume : 6
Pagina's : 64

Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) versus chemotherapy in luminal B early breast cancer: lessons from the CORALLEEN trial.

Auteurs : de Angelis C, Ignatiadis M, Piccart-Gebhart M
Jaar : 2020
Journal : Ann Transl Med
Volume : 8
Pagina's : 1338

Neoadjuvant immunotherapy in breast cancer: a paradigm shift?

Auteurs : Fountzila E, Ignatiadis M
Jaar : 2020
Journal : Ecancermedicalscience
Volume : 14
Pagina's : 1147

Clinical management of first-line advanced triple-negative breast cancer patients

Auteurs : Rediti M, Punie K, de Azambuja E, Naert E, Taylor D, Duhoux FP, Denys H, Awada A, Wildiers H, Ignatiadis M
Jaar : 2020
Journal : Belgian J Medical Oncology
Volume : 14(7)
Pagina's : 333-338